一项实践中的试点研究评估了勃起功能障碍患者对阿凡纳菲尔治疗的满意度
Ping-Ju Tsai1, Shih-Ya Hung1, Tsung-Hsi Lee1
1Division of Urology, Department of Surgery, Yuan's General Hospital, No. 136, Siwei 4th Road, Lingya District, Kaohsiung City 802793, Taiwan, Republic of China.
Sexual medicine
|February 8, 2024
概括
阿瓦纳菲尔在现实环境中显著改善勃起功能 (ED) 和治疗满意度. 影响满意度的关键因素包括患者特征和ED严重程度,指导更好的治疗结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 男人的健康 男人健康
背景情况:
- 阿瓦纳菲尔是一种快速起作用的固酶5型 (PDE5) 抑制剂,缺乏关于治疗满意度的真实数据.
- 了解患者满意度对于优化勃起功能障碍 (ED) 管理至关重要.
研究的目的:
- 为了评估阿凡纳菲尔对ED的现实世界治疗结果.
- 确定影响患者对阿凡纳菲尔治疗满意度的因素.
主要方法:
- 第4期,开放标签,观察性研究,涉及ED患者处方阿瓦纳菲尔.
- 通过调查问卷收集的数据评估了阿凡纳菲尔的使用,不良事件,ED严重程度和治疗满意度 (SHIM,EDITS).
主要成果:
- 阿瓦纳菲尔显著改善了平均SHIM分数 (10.2至17.5,P<.001).
- 87.5%的患者表示满意 (EDITS分数≥60).
- 年龄较小,腰围较小,ED持续时间较短等因素与更高的满意度相关.
结论:
- 阿瓦纳菲尔在现实世界ED治疗中表现出高效率和患者满意度.
- 确定满意度预测因素可以提高治疗策略和结果.
- 这项研究提供了关于阿凡纳菲尔的有效性和患者报告结果的有价值的现实证据.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
158
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
158
Male Sexual Response: Erection & Ejaculation
2.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181


